건강보험심사평가원이 수행해야 하는 진정한 의무: 의료급여 혈액투석 수가 중심으로

Abstract

In 2001, the medical aid hemodialysis benefits system was established, but it has fundamental problems. These fundamental problems have been necessary to improve medical aid hemodialysis benefits as they have served as conditions for promoting discriminatory care invisible to actual care environments, resulting in self-evident consequences that eventually harm patients. In order to improve the problem of medical aid hemodialysis benefits, many efforts have been made to improve medical aid hemodialysis benefits in various fields by conducting a petition to the Korea Kidney Patients Association in 2005, a policy forum to secure health rights for patients and the underprivileged in 2010, and an investigation study of health insurance hemodialysis cost in 2012. As a result of the efforts, hemodialysis costs, which have been unreasonable for the past 20 years, have shifted from a case payment to a resource-based relative value scale since April 1, 2021, creating an environment in which hemodialysis patients' medical quality can be improved. With medical aid hemodialysis benefits strengthened, it will be necessary for patients, doctors, and Health Insurance Review & Assessment Service (HIRA) to make efforts to maintain a high-quality medical environment for patients with kidney disease. Therefore, endeavor to improve the quality of care for patients with kidney disease, including improvements in medical aid hemodialysis benefits, can be considered one of the true obligations of HIRA.